Knowledge shared.Possibility multiplied.
Explore our research, company updates, and materials for partners and the wider scientific community.
Explore resources
OPEN COMMUNICATION
Shared knowledge.
Stronger connections.
Our resource hub connects you with company information and scientific materials. Contact the relevant team for the latest available versions.
For press use, please request approved materials through our communications team.
RESOURCE LIBRARY
Find the right starting point.
6 resources
Corporate overview
An introduction to Apterna, REGEN001, and the development strategy.
Request materialCompany materialsPlatform summary
Information on liver-directed RNA and broader delivery capabilities.
Request materialCompany materialsCompany fact sheet
A concise overview of the company, leadership, and research focus.
Request materialMediaBrand & media kit
Approved logo files, company information, and media materials.
Request materialResearchResearch publications
Request references and materials relating to Apterna’s scientific approach.
Request materialResearchConference presentations
Request available posters and scientific presentations.
Request materialBRAND & MEDIA
A clear and consistent voice.
For logo assets, company descriptions, interviews, and photography requests, contact press@apterna.com.
Contact communicationsCONTINUE EXPLORING
Explore what comes next.
A CLEARER UNDERSTANDING
Questions about our work.
How can I request Apterna’s scientific or investor materials?
Choose a resource in the library to open its dedicated enquiry form. Each form includes a suggested subject and message and routes the request to the relevant Apterna team.
Are the published investment scenarios forecasts?
No. The March 2026 REGEN001 scenarios are illustrative company-published assumptions. They are not guarantees of returns or established future outcomes.